These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 1335257)

  • 21. Pharmacological profile of the new antidepressant levoprotiline.
    Noguchi S; Okada M; Inukai T
    Arzneimittelforschung; 1992 Jun; 42(6):787-94. PubMed ID: 1418032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. General pharmacological properties of the potent angiotensin converting enzyme inhibitor rentiapril.
    Yamauchi H; Nishimura K; Nakata K; Suda H; Iso T; Shimizu M; Hiramatsu Y
    Arzneimittelforschung; 1987 Feb; 37(2):157-64. PubMed ID: 3034298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. General pharmacological properties of YJA20379-8, a new H+/K(+)-ATPase inhibitor with anti-ulcer activities.
    Lee EB; Cho SI; Chang HO; Chang MS; Kim KB; Lee SB; Choi WS
    Arzneimittelforschung; 2001; 51(8):659-66. PubMed ID: 11556127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of methyl O-(4-hydroxy-3-methoxycinnamoly)reserpate (CD-3400) on the peripheral nervous system: especially on the smooth muscle organs].
    Miyake N; Hasegawa Y; Tamada T; Fujimoto Y
    Nihon Yakurigaku Zasshi; 1976 Nov; 72(8):991-1000. PubMed ID: 14872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [General pharmacology of traxanox sodium. I. Effects on the central, somatic, and autonomic nervous systems, digestive system, urologic organs, and reproductive system].
    Goto K; Osuga K; Haga K; Tsumagari T
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):343-63. PubMed ID: 6629211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive and general pharmacological properties of budralazine.
    Chiba T; Shibamura S; Tanaka M; Yamasaki T; Hashimoto H; Kurebayashi Y; Kasai Y; Ryokawa Y; Tamura K; Hirohashi M; Akashi A
    Arzneimittelforschung; 1981; 31(7):1080-7. PubMed ID: 7023495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [General pharmacology of T-3761, a new oral quinolone antibacterial agent (2). Effect on the respiratory and cardiovascular systems, autonomic nervous system and other functions].
    Furuhata K; Hiraiwa T; Terashima N; Arai H; Ono S; Hashiba K; Maekawa M; Kitamura K; Nakada Y; Mori Y
    Jpn J Antibiot; 1995 May; 48(5):706-32. PubMed ID: 7637205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. General pharmacology of the new antiviral agent SK 1899.
    Ryu KH; Rhee HI; Jung I; Kim TS; Lee SJ; Im GJ; Lee N; Ryu DH; Kim YW; Kim JJ; Chang K; Lee BH; Shin HS; Kim EJ; Kim KH; Kim DK
    Arzneimittelforschung; 2000 Apr; 50(4):395-403. PubMed ID: 10800640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. General pharmacological properties of YJA 20379-1, a novel proton pump inhibitor with antiulcer activities.
    Lee EB; Cho SI; Cheon SA; Chang MS; Kim KB; Sohn SK; Chung YK
    Arzneimittelforschung; 1999 Dec; 49(12):1018-24. PubMed ID: 10635448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part III: Smooth muscle, gastrointestinal and miscellaneous systems.
    Hirohashi M; Takasuna K; Kasai Y; Usui C; Kojima H
    Arzneimittelforschung; 1991 Jan; 41(1):25-31. PubMed ID: 1675570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. General pharmacology of [2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3- dihydro-1H-pyrrolizine-5-yl]-acetic acid in experimental animals.
    Algate DR; Augustin J; Atterson PR; Beard DJ; Jobling CM; Laufer S; Munt PL; Tries S
    Arzneimittelforschung; 1995 Feb; 45(2):159-65. PubMed ID: 7710439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacological studies on oxatomide: (6) Effect on the peripheral organs].
    Ohmori K; Ishii H; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):79-104. PubMed ID: 6133821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General pharmacology of the non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Hayashi M; Kajiwara Y; Kitabatake K; Uruno T; Kubota K
    Arzneimittelforschung; 1993 Nov; 43(11):1169-74. PubMed ID: 8292059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General pharmacology of cis-malonato[4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II).
    Kim DK; Ahn JS; Ryu G; Kim KH; Park CW; Kim MS; Chung MH; Shin SG; Suh YH; Kim YS
    Arzneimittelforschung; 1994 Sep; 44(9):1080-8. PubMed ID: 7986249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: Effects on the central nervous system.
    Shintani S; Toba Y; Suzuki S; Ninomiya S; Umezato M; Hiyama T
    Arzneimittelforschung; 1985; 35(7A):1157-62. PubMed ID: 4074429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacological studies on oxatomide. (5). Effect on the central and peripheral nervous systems].
    Ohmori K; Ishii H; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1983 Mar; 81(3):245-66. PubMed ID: 6134657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [General pharmacological studies on isepamicin sulfate (HAPA-B)].
    Shibata K; Mita I; Shinoda Y; Nakano U; Kinoshita H; Noguchi M; Uzawa T; Sohmiya Y; Takayanagi N
    Jpn J Antibiot; 1987 Jan; 40(1):145-69. PubMed ID: 3586327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.